Applications published 9 September 2009

Poly-TLR antagonist
Cadila Pharmaceuticals 2096914*

Metabolically-stabilised inhibitors of fatty acid amide hydrolase
NV Organon 2096915*

Compounds and methods for treating oestrogen receptor-related diseases
Shenogen Pharma Group 2096916*

Cyclopamine analogues
Infinity Discovery 2096917*

Substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis
Bayer Schering Pharma 2096919*

Triazole formulation
Syngenta 2096920*

Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
China Medical University 2096924*

A heterogeneously configured multiparticulate gastrointestinal drug delivery system
University of the Witwatersrand 2097067*

Formulations of PEG-interferon alpha conjugates
Cadila Healthcare 2097068*

Robust sustained release formulations of oxymorphone
Penwest Pharmaceuticals 2097069*

Robust sustained release formulations of oxymorphone and methods of use thereof
Penwest Pharmaceuticals 2097070*

Pharmaceutical compsn of memantine
Pliva-Istrazivanje i Razvoj 2097071*

Method of producing microcapsules
The Royal College of Surgeons in Ireland 2097072*

Stable and ready-to-use oil-in-water propofol microemulsion
Cristalia Produtos Quimicos Farmaceuticos 2097073*

Topical pharmaceutical compsn
SmithKline Beecham 2097074*

Use of adapalene for modulating the expression of CD10 or IL-10
Galderma Research &?Development 2097075*

Use of adapalene for modulating the expression of IL-1RA
Galderma Research &?Development 2097076*

Benzoyl peroxide comprising compsns, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use
Galderma Research &?Development 2097077*

Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
Abraxis BioScience 2079078*

Modulation of prostaglandin/cyclooxygenase metabolic pathways
Hunter-Fleming 2097079*

Use of an indazolemethyoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
Aziende Chimiche Riunite Angelini Francesco 2097080*

Cholesterylamines for the treatment and prevention of infectious diseases
Jado Technologies; Technische Universitaet Dresden 2097081*

Pharmaceutical compsn comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis
SNU?R&DB?Foundation 2097082*

Dosage forms and co-administration of an opioid agonist and an opioid antagonist
Nektar Therapeutics 2097083*

Carboxamide 4-[(4-pyridyl)amino] pyrimidines for the treatment of hepatitis C
Tibotec Pharmaceuticals 2097084*

Therapeutic materials and methods
Ariad Pharmaceuticals 2097085*

Suppressive macrophages, C-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura
STC.UNM 2097087*

Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
University of Pittsburgh 2097088*

Peptide and treatment for HIV-1 infection
Thomas Jefferson University 2097090*

Conjugate of natriuretic peptide and antibody constant region
PDL?BioPharma 2097091*

Therapeutic and diagnostic peptides
Susavion Biosciences 2097093*

Novel compsns and uses thereof
Avaris 2097099*

Compounds and methods for amino-alkylenediol synthesis
F?Hoffmann-La Roche 2097370*

Benzocycloheptyl analogues having sphingosine 1-phosphate receptor activity
University of Virginia Patent Foundation 2097371*

Process for the preparation of memantine and its hydrochloric acid salt form
KRKA 2097372*

Sulphonamide derivatives as liver carnitine palmitoyl transferase (L-CPTL)
F Hoffmann-La Roche 2097373*

5-alkoxyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of V2 vasopressin receptors
Sanofi-Aventis 2097374*

Method for purifying bisimides
Sabic Innovative Plastics 2097375*

Spiro-piperidine derivatives
F?Hoffmann-La Roche 2097376*

Renin inhibitors
Merck Frosst Canada 2097377*

Novel SEH?inhibitors and their use
SmithKline Beecham 2097378*

Carboxamide derivatives as ion channel modulators
Wyeth 2097379*

New haloalkylsulphone substituted compounds useful for treating obesity and diabetes
High Point Pharmaceuticals 2097380*

4-[4-({[4-chloro-3-trifluoro-methyl)phenyl)]carbmoyl}amino)-3-fluorophenox]-N-methylpyridine-2-carboxamide monohydrate
Bayer Schering Pharma 2097381*

Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO?synthase
Sanofi-Aventis 2097382*

Process for preparation of IVAB-radine hydrochloride
Cadila Healthcare 2097383*

Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
AstraZeneca 2097384*

2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[F]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
Merck 2097385*

Substituted dihydroimidazoles and their use in the treatment of tumours
Novartis 2097386*

Heterocyclic aspartyl protease inhibitors
Schering; Pharmacopeia 2097387*

Novel 2-(20hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
High Point Pharmaceuticals 2097388*

Sulphated benzimidazolone derivatives having mixed serotonine receptor affinity
Boehringer Ingelheim International 2097389*

Amino quinazolines derivatives with blood platelet reducing properties
Shire 2097390*

2-(2hydroxyphenyl)-quinazolin-4-ones useful for treating obesity and diabetes
High Point Pharmaceuticals 2097391*

1,2,3-triazole derivatives as sigma receptor inhibitors
Laboratoires Del Dr Esteve 2097392*

Therapeutic G-quadruplex ligands
School of Pharmacy, University of London 2097393*

1,2,4-triazole derivatives as sigma receptor inhibitors
Laboratoires del Dr Esteve 2097394*

Process for the preparation of valsartan and intermediate products
Ratiopharm 2097395*

Process for the preparation of 5-hydroxy-isozolidines, 5-isoxazolidinones, B-amino acids, B-amino aldehydes and derivatives thereof
Cordova, Armando 2097396*

Tetralin-analogue having sphingosine 1-phosphate agonist activity
University of Virginia Patent Foundation 2097397*

Process for producing amorolofine
Galderma 2097398*

Novel inhibitors of chymase
Janssen Pharmaceutica 2097399*

Fused substituted aminopyrrolidine derivative
Daiichi Sankyo 2097400*

Process for the preparation of (3R,4R)-N-(4-chlorophenyl)-1-(2,2-difluoroethyl)-N"-[2-fluoro-4-(2-oxo-1 (2H)-pyridinyl)phenyl]-3,4-pyrrolidinedicarboxamide
F?Hoffmann-La Roche 2097401*

Macrocyclic inhibitors of hepatitis C?virus
Tibotec Pharmaceuticals 2097402*

New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate
Boehringer Ingelheim International 2097403*